1. Calabro-Jones PM, Aguilera JA, Ward JF. Uptake of Wr-2721 derivatives by cells in culture: Identification of the transported form of the drug. Cancer Res 1988;48:3634–3640.
2. Calabro-Jones PM, Aguilera JA, Ward JF, et al. The limits to radioprotection of Chinese hamster V79 cells by WR-1065 under areobic conditions. Radiat Res 1998;149:550–559.
3. Davidson DE, Grenan MM, Sweeney TR. Biological characteristics of some improved radioprotectors. In: Brady LW, ed. Radiation sensitizers: Their use in clinical management of cancer. New York: Masson, 1980:309.
4. Dorr, RT, Lagel, KE. Anthracycline cardioprotection by amifostine (WR2721) and its active metabolite in vitro. Proc Am Soc Clin Oncol 1994; 13:435.abstract.
5. Fahey RC. HPLC analysis of thiols using monobromobimane fluorescent labeling: Applications to radioprotective drugs. In: Miquel J, Quintanilha A, Weber H, eds. Handbook of biomedicine of free radicals and antioxidants. Boca Raton, Fla.: CRC Press, 1989:265–70.